NVIDIA
NVDA
Adobe
ADBE
Tesla
TSLA
4
Netflix
NFLX
5
Qualcomm
QCOM
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.